AIMS: Dual therapy comprising G-CSF for mobilization of bone marrow-derived progenitor cells (BMPCs), with simultaneous pharmacological inhibition of dipeptidylpeptidase-IV for enhanced myocardial recruitment of circulating BMPC via the SDF-1α/CXCR4-axis, has been shown to improve survival after acute myocardial infarction (AMI). Using an innovative method to provide non-invasive serial in vivo measurements and information on metabolic processes, we aimed to substantiate the possible effects of this therapeutic concept on cardiac remodelling after AMI using 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET). METHODS AND RESULTS: AMI was induced in C57BL/6 mice by performing surgical ligation of the left anterior descending artery in these mice. Animals were then treated with granulocyte-colony stimulating factor + Sitagliptin (GS) or placebo for a duration of 5 days following AMI. From serial PET scans, we verified that the infarct size in GS-treated mice (n = 13) was significantly reduced at Day 30 after AMI when compared with the mice receiving placebo (n = 10). Analyses showed a normalized FDG uptake on Day 6 in GS-treated mice, indicating an attenuation of the cardiac inflammatory response to AMI in treated animals. Furthermore, flow cytometry showed a significant increase in the anti-inflammatory M2-macrophages subpopulation in GS-treated animals. In comparing GS treated with placebo animals, those receiving GS-therapy showed a reduction in myocardial hypertrophy and left ventricular dilatation, which indicates the beneficial effect of GS treatment on cardiac remodelling. Remarkably, flow cytometry and immunohistochemistry showed an increase of myocardial c-kit positive cells in treated mice (n = 12 in both groups). CONCLUSION: Using the innovative method of micro-PET for non-invasive serial in vivo measurements of metabolic myocardial processes in mice, we were able to provide mechanistic evidence that GS therapy improves cardiac regeneration and reduces adverse remodelling after AMI. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Dual therapy comprising G-CSF for mobilization of bone marrow-derived progenitor cells (BMPCs), with simultaneous pharmacological inhibition of dipeptidylpeptidase-IV for enhanced myocardial recruitment of circulating BMPC via the SDF-1α/CXCR4-axis, has been shown to improve survival after acute myocardial infarction (AMI). Using an innovative method to provide non-invasive serial in vivo measurements and information on metabolic processes, we aimed to substantiate the possible effects of this therapeutic concept on cardiac remodelling after AMI using 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET). METHODS AND RESULTS: AMI was induced in C57BL/6 mice by performing surgical ligation of the left anterior descending artery in these mice. Animals were then treated with granulocyte-colony stimulating factor + Sitagliptin (GS) or placebo for a duration of 5 days following AMI. From serial PET scans, we verified that the infarct size in GS-treated mice (n = 13) was significantly reduced at Day 30 after AMI when compared with the mice receiving placebo (n = 10). Analyses showed a normalized FDG uptake on Day 6 in GS-treated mice, indicating an attenuation of the cardiac inflammatory response to AMI in treated animals. Furthermore, flow cytometry showed a significant increase in the anti-inflammatory M2-macrophages subpopulation in GS-treated animals. In comparing GS treated with placebo animals, those receiving GS-therapy showed a reduction in myocardial hypertrophy and left ventricular dilatation, which indicates the beneficial effect of GS treatment on cardiac remodelling. Remarkably, flow cytometry and immunohistochemistry showed an increase of myocardial c-kit positive cells in treated mice (n = 12 in both groups). CONCLUSION: Using the innovative method of micro-PET for non-invasive serial in vivo measurements of metabolic myocardial processes in mice, we were able to provide mechanistic evidence that GS therapy improves cardiac regeneration and reduces adverse remodelling after AMI. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Hans D Theiss; Markus Vallaster; Christoph Rischpler; Lisa Krieg; Marc-Michael Zaruba; Stefan Brunner; Yordan Vanchev; Rebekka Fischer; Michael Gröbner; Bruno Huber; Timm Wollenweber; Gerald Assmann; Josef Mueller-Hoecker; Markus Hacker; Wolfgang-M Franz Journal: Stem Cell Res Date: 2011-05-16 Impact factor: 2.020
Authors: William Chan; Stephen J Duffy; David A White; Xiao-Ming Gao; Xiao-Jun Du; Andris H Ellims; Anthony M Dart; Andrew J Taylor Journal: JACC Cardiovasc Imaging Date: 2012-09
Authors: C Brenner; W M Franz; S Kühlenthal; K Kuschnerus; F Remm; L Gross; H D Theiss; U Landmesser; N Kränkel Journal: Int J Cardiol Date: 2015-07-13 Impact factor: 4.164
Authors: Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field Journal: Nature Date: 2004-03-21 Impact factor: 49.962
Authors: Marc-Michael Zaruba; Bruno C Huber; Stefan Brunner; Elisabeth Deindl; Robert David; Rebekka Fischer; Gerald Assmann; Nadja Herbach; Sebastian Grundmann; Ruediger Wanke; Josef Mueller-Hoecker; Wolfgang-Michael Franz Journal: Cardiovasc Res Date: 2007-11-30 Impact factor: 10.787
Authors: Neil Ruparelia; Janet E Digby; Andrew Jefferson; Debra J Medway; Stefan Neubauer; Craig A Lygate; Robin P Choudhury Journal: Inflamm Res Date: 2013-03-08 Impact factor: 4.575
Authors: Andrei Todica; Nick L Beetz; Lisa Günther; Mathias J Zacherl; Ulrich Grabmaier; Bruno Huber; Peter Bartenstein; Stefan Brunner; Sebastian Lehner Journal: Mol Imaging Biol Date: 2018-04 Impact factor: 3.488
Authors: Mia Ståhle; Ville Kytö; Max Kiugel; Heidi Liljenbäck; Olli Metsälä; Meeri Käkelä; Xiang-Guo Li; Vesa Oikonen; Pekka Saukko; Pirjo Nuutila; Juhani Knuuti; Anne Roivainen; Antti Saraste Journal: J Nucl Cardiol Date: 2018-12-13 Impact factor: 5.952
Authors: Maximilian Fischer; Tobias Weinberger; Guido Boening; Andrei Todica; Denise Messerer; Mathias J Zacherl; Christian Schulz; Steffen Massberg; Peter Bartenstein; Sebastian Lehner Journal: Ann Nucl Med Date: 2022-03-30 Impact factor: 2.258
Authors: U Grabmaier; G Kania; J Kreiner; J Grabmeier; A Uhl; B C Huber; K Lackermair; N Herbach; A Todica; U Eriksson; L T Weckbach; S Brunner Journal: PLoS One Date: 2016-08-08 Impact factor: 3.240